Vital Therapies prices offering
Second Sight Medical eyes $3m bridge to IPO
Second Sight Medical is looking to bridge the gap to its forthcoming initial public offering with a $3 million loan from iconic chairman Al Mann.
TAVI: Direct Flow Medical wins CE Mark for enhanced heart valve delivery device
Zimmer adds Harvard spinout Etex Corp.
Masimo wins $467m verdict in patent spat with Philips
LoneStar Heart wins CE Mark for hydrogel heart implant
Laguna Hills, Calif.-based LoneStar Heart said it won CE Mark approval in the European Union for its Algisyl-LVR hydrogel implant for the treatment of advanced heart failure.
UCLA spinout NeuroSigma seeks $50m in IPO
NeuroSigma aims to reap as much as $50.2 million in its upcoming initial public offering for the UCLA spinout’s noninvasive system to treat drug-resistant epilepsy.
NeuroSigma plans to sell 3.6 million shares on the NASDAQ exchange for between $13 and $15 each, reserving the symbol NSIG, according to a regulatory filing.
Medtronic, Covidien name peripherals biz transition team
FDA launches cybersecurity initiative
The FDA is asking medical device manufacturers to submit documentation about cybersecurity controls they have in place to mitigate the threat of hackers accessing devices, including ongoing software patches and updates to operating systems.
EndoStim targets $36m IPO
EndoStim said it hopes to raise nearly $36 million in an initial public offering, with plans to plow $10 million into clinical studies of its system to treat severe gastroesophageal reflux disease and another $14 million to commercialize the system.
Acutus Medical pulls in $26M
Acutus Medical said it secured $26.2 million in new funding for the cardiac mapping technology it’s developing to image and map atrial fibrillation hotspots.
